Pini Orbach, Ph.D., has served as our director since October 2014. Dr. Orbach has 10 years of experience in executive positions. As of February 2010 Dr. Orbach is the head of Pharma and Life Science at Arkin Holdings. Dr. Orbach is the Chief Executive Officer of NanoDoc Technology, Inc., and a board member at HealOr Ltd. Prior to joining Arkin Holdings, Dr. Orbach served as Chief Executive Officer of several Health Care companies in Israel and abroad. Dr. Orbach serves as Director at Metallo-Therapy Ltd., Chairman of the Board of cCAM Biotherapeutics Ltd. He also serves as a Director of FusiMab Ltd., and Quiet Therapeutics Ltd. He received his Ph.D. from the Department of Physiology and Functional Genomics, University of Florida, and was a postdoctoral fellow at the Cardiovascular Research Center, Harvard Medical School.

Pini Orbach, Ph.D., has served as our director since October 2014. Dr. Orbach has 10 years of experience in executive positions. As of February 2010 Dr. Orbach is the head of Pharma and Life Science at Arkin Holdings. Dr. Orbach is the Chief Executive Officer of NanoDoc Technology, Inc., and a board member at HealOr Ltd. Prior to joining Arkin Holdings, Dr. Orbach served as Chief Executive Officer of several Health Care companies in Israel and abroad. Dr. Orbach serves as Director at Metallo-Therapy Ltd., Chairman of the Board of cCAM Biotherapeutics Ltd. He also serves as a Director of FusiMab Ltd., and Quiet Therapeutics Ltd. He received his Ph.D. from the Department of Physiology and Functional Genomics, University of Florida, and was a postdoctoral fellow at the Cardiovascular Research Center, Harvard Medical School.